Search Results for "Interleukin Genetics Clinical Studies"
Original Source: Interleukin Genetics, Inc.
Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the...
Matching Channels
Interleukin 6 IL 6 Receptor IL 6R
Although the causes of rheumatoid arthritis are not fully understood, constitutive overproduction of interleukin-6 (IL-6), a multifunctional cytokine that regulates immune response, inflammatory react...
Matching News
Interleukin Genetics, Inc. Announces Conference Call to Discuss Fourth Quarter 2012 Results
Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that it will host a conference call and Webcast on Thursday, March 28, 2013 at 4:30 p.m. (EST) to discuss the Compa...
Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2012 Results
Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that it will host a conference call and Webcast on Tuesday, August 14, 2012 at 4:30 p.m. ET to discuss the Company’s sec...
Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2013 Results
Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that it will host a conference call and Webcast on Thursday, May 23, 2013 at 4:30 p.m. (EST) to provide a corporate...
Interleukin Genetics, Inc. Announces Conference Call to Discuss Third Quarter 2012 Results
Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that it will host a conference call and Webcast on Wednesday, November 14, 2012 at 4:30 p.m. ET to discuss the Company’s...
CEO of Interleukin leaves post
Lewis Bender has stepped down as CEO of Interleukin Genetics, a maker of genetic tests for specific chronic diseases, effecti -More-
[Interleukin Genetics] nets $11.2mm via PIPE
Personalized health company [Interleukin Genetics Inc.] netted $11.2mm through the sale of 43.7mm common shares at $0.27 (a 34% discount) to Bay City Capital (20.6mm), Growth Equity Opportunities Fund...
Interleukin Genetics management update
Interleukin Genetics completes private placement of convertible preferred stock
Matching PubMed Articles
Acute Exposure to 50-Hz Magnetic Fields Increases Interleukin-6 in Young Healthy Men.
Some epidemiologic studies have suggested that extremely low frequency magnetic fields might affect human health and, in particular, that the incidence of certain types of cancer might increase among...
The genetics of contact allergy (CA) is still only partly understood, despite decades of research. This might be due to inadequately defined phenotypes used in the past. Therefore we suggested studyin...
Association between the interleukin-4, interleukin-13 polymorphisms and asthma: a meta-analysis.
A numbers studies had been reported that the polymorphisms in the Interleukin 4 (IL-4) and Interleukin 13 (IL-13) genes were associated with susceptibility to asthma. However, the results were inconsi...
Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs) have TIR intracellular domains that engage two main signaling pathways, via the TIR-containing adaptors MyD88 (which is not used by TLR3...
